Dr. Erin Overstreet is the Executive Director of the USC Stevens Center for Innovation with more than 16 years of experience in academic technology transfer, licensing, industry partnerships, and research administration. She oversees the day-to-day operations of the office, manages the university’s extensive IP portfolio, facilitates collaboration between university researchers and industry partners, supports the formation of startups on the commercialization path, and brings inventions to market for the betterment of society.
A seasoned executive, Dr. Overstreet has vast experience working with early-stage technologies and companies, and has held leadership roles at the University of California, San Francisco, and the University of Texas at Austin. Most recently, she was Head of Corporate Strategy at a cancer immune-oncology company, Delta TpX, where she gained first-hand operational experience in forming and financing early-stage companies. Throughout her career, she has worked closely with faculty and researchers to license more than 200 technologies and assisted over 40 startups in their journey to spin out from universities, which collectively raised $500+ million in VC funding including three IPOs. She has broad experience in evaluating early-stage technologies, refining and protecting key IP, marketing to industry partners, and negotiating deals that mature the technology and lead to commercialization.
Dr. Overstreet holds a Ph.D. in Molecular Biology and a BS in Microbiology from the University of Texas at Austin.